Zhejiang DiAn Diagnostics Co Market Cap ($1.80 Billion)
Market Cap & Net Worth: Zhejiang DiAn Diagnostics Co (300244)
Zhejiang DiAn Diagnostics Co market cap. Zhejiang DiAn Diagnostics Co (SHE:300244) has a market capitalization of $1.80 Billion (CN¥12.29 Billion) as of November 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #6278 globally and #1170 in its home market, demonstrating a -7.70% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhejiang DiAn Diagnostics Co's stock price CN¥19.66 by its total outstanding shares 624979436 (624.98 Million). Also see 300244 cash flow conversion for how efficiently the company converts equity into cash flow.
Zhejiang DiAn Diagnostics Co Market Cap History (2015–2026)
Zhejiang DiAn Diagnostics Co market cap history from 2015 to 2026. Data shows change from $3.20 Billion to $1.80 Billion (-6.11% CAGR). Check today's stock price for Zhejiang DiAn Diagnostics Co for real-time trading data and today's change.
Zhejiang DiAn Diagnostics Co Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhejiang DiAn Diagnostics Co's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 300244 year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.14x
Zhejiang DiAn Diagnostics Co's market cap is 0.14 times its annual revenue
Latest Price to Earnings (P/E) Ratio
32.90x
Zhejiang DiAn Diagnostics Co's market cap is 32.90 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.66 Billion | $3.82 Billion | $262.76 Million | 0.69x | 10.11x |
| 2017 | $1.96 Billion | $5.00 Billion | $349.59 Million | 0.39x | 5.61x |
| 2018 | $1.26 Billion | $6.97 Billion | $388.61 Million | 0.18x | 3.25x |
| 2019 | $1.84 Billion | $8.45 Billion | $347.28 Million | 0.22x | 5.31x |
| 2020 | $2.87 Billion | $10.65 Billion | $802.93 Million | 0.27x | 3.57x |
| 2021 | $2.82 Billion | $13.08 Billion | $1.16 Billion | 0.22x | 2.42x |
| 2022 | $2.12 Billion | $20.28 Billion | $1.43 Billion | 0.10x | 1.48x |
| 2023 | $2.02 Billion | $13.41 Billion | $307.46 Million | 0.15x | 6.58x |
| 2024 | $1.04 Billion | $12.20 Billion | -$357.28 Million | 0.09x | N/A |
| 2025 | $1.45 Billion | $10.10 Billion | $44.05 Million | 0.14x | 32.90x |
Competitor Companies of 300244 by Market Capitalization
Companies near Zhejiang DiAn Diagnostics Co in the global market cap rankings as of November 4, 2026. Also see Zhejiang DiAn Diagnostics Co total assets for a full breakdown of the balance sheet.
Key companies related to Zhejiang DiAn Diagnostics Co by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #87 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #142 globally with a market cap of $162.54 Billion USD.
- Natera Inc (NASDAQ:NTRA): Ranked #479 globally with a market cap of $56.02 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #546 globally with a market cap of $48.96 Billion USD ( CN¥334.59 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #87 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $698.34 |
| #142 | Danaher Corporation | NYSE:DHR | $162.54 Billion | $230.11 |
| #479 | Natera Inc | NASDAQ:NTRA | $56.02 Billion | $388.63 |
| #546 | WuXi AppTec Co Ltd | SHG:603259 | $48.96 Billion | CN¥135.28 |
Market Capitalization of Zhejiang DiAn Diagnostics Co (2015–2026)
Market capitalization of Zhejiang DiAn Diagnostics Co from 2015 to today. Between 2015 and today, Zhejiang DiAn Diagnostics Co's market cap moved from $3.20 Billion to $ 1.80 Billion, with a yearly change of -6.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.80 Billion | +24.04% |
| 2025 | CN¥1.45 Billion | +39.65% |
| 2024 | CN¥1.04 Billion | -48.67% |
| 2023 | CN¥2.02 Billion | -4.54% |
| 2022 | CN¥2.12 Billion | -24.80% |
| 2021 | CN¥2.82 Billion | -1.73% |
| 2020 | CN¥2.87 Billion | +55.47% |
| 2019 | CN¥1.84 Billion | +46.09% |
| 2018 | CN¥1.26 Billion | -35.70% |
| 2017 | CN¥1.96 Billion | -26.13% |
| 2016 | CN¥2.66 Billion | -17.03% |
| 2015 | CN¥3.20 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Zhejiang DiAn Diagnostics Co was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.80 Billion USD |
| MoneyControl | $1.80 Billion USD |
| MarketWatch | $1.80 Billion USD |
| marketcap.company | $1.80 Billion USD |
| Reuters | $1.80 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Zhejiang DiAn Diagnostics Co
Dian Diagnostics Group Co.,Ltd. provides integrated medical diagnostics solutions with independent diagnostic services in China. The company offers laboratory supplies and kits; AI-assisted digital pathology diagnosis solutions, such as nucleic acid extraction and purification system, automatic liquid-based cytology slide preparation and staining system, digital pathology slide scanner, automated… Read more